Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.53 |
| ▸ | GLS2 | Q9UI32 | 3/20 | 0.48 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.44 |
| ▸ | PTAFR | P25105 | 1/20 | 0.44 |
| ▸ | HTR1D | P28221 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3229513 | 0.98 | PRKCA (0.51) | PRKCAGLS2ADRA1DPTAFRHTR1D | |
| SCHEMBL4019497 | 0.90 | PRKCA (0.53) | PRKCAGLS2FAAHGPR84 | |
| SCHEMBL6681613 | 0.90 | PRKCA (0.53) | PRKCAGLS2FAAHGPR84 | |
| SCHEMBL11766121 | 0.90 | PRKCA (0.53) | PRKCAGLS2FAAHGPR84 | |
| SCHEMBL12060210 | 0.90 | PRKCA (0.53) | PRKCAGLS2FAAHGPR84 | |
| SCHEMBL9851888 | 0.90 | PRKCA (0.53) | PRKCAGLS2FAAHGPR84 | |
| SCHEMBL12060199 | 0.90 | PRKCA (0.53) | PRKCAGLS2FAAHGPR84 | |
| SCHEMBL13752433 | 0.90 | PRKCA (0.53) | PRKCAGLS2FAAHGPR84 | |
| SCHEMBL10454594 | 0.90 | PRKCA (0.53) | PRKCAGLS2FAAHGPR84 | |
| SCHEMBL11356716 | 0.90 | PRKCA (0.53) | PRKCAGLS2FAAHGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8580235-B2 | Hair cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2013-11-12 | — | — | US | disclosed |
| EP-2305207-B1 | HAIR COSMETIC | SHISEIDO CO LTD (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20110110877-A1 | Hair Cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2011-05-12 | — | — | US | disclosed |
| EP-2305207-A1 | HAIR COSMETIC | Shiseido Company, Ltd. (JP) | 2011-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110110877-A1 | Hair Cosmetic | PCNA, CYP51A1, CYP17A1 | PRKCA 3981/4885GLS2 4404/4885ADRA1D 2159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.